DCGI

Expert panel recommends trials for Bharat Biotech’s nasal vaccine

Representative Image NEW DELHI- A panel of drug regulatory organisation Central Drugs Standard Control Organisation (CDSCO) recommended permitting the Phase…

4 years ago

India’s first CRISPR COVID-19 Test receives approval for commercial launch

Representative Image NEW DELHI: Drug Controller General of India (DCGI) approved a low-cost COVID-19 test developed by the Council of…

4 years ago

DCGI gives nod to SII to recommence Oxford COVID vaccine trials

Representative Image NEW DELHI: Dr. Venugopal G Somani, Drugs Controller General of India (DCGI), on Tuesday, September 15, withdrew the…

4 years ago

Oxford University, AstraZeneca’s vaccine trials resumed in UK

Representative Image NEW DELHI: AZD1222, Oxford University and AstraZeneca’s COVID vaccine candidate, is considered to be one of the first…

4 years ago

Cipla prices its generic remdesivir at Rs 4,000 a vial

Representative Image BENGALURU: The Indian drug maker Cipla Ltd., on Wednesday, July 8, said that it has priced its generic…

4 years ago

ICMR aims to launch indigenous COVID-19 vaccine by August 15

Representative Image NEW DELHI: The Indian Council of Medical Research (ICMR) said that it aims to launch an indigenously developed…

4 years ago